ABBV
$180.82
Revenue | $14460Mn |
Net Profits | $1561Mn |
Net Profit Margins | 10.8% |
Abbvie Inc’s revenue jumped 3.83% since last year same period to $14460Mn in the Q3 2024. On a quarterly growth basis, Abbvie Inc has generated -0.01% fall in its revenue since last 3-months.
Abbvie Inc’s net profit fell -12.2% since last year same period to $1561Mn in the Q3 2024. On a quarterly growth basis, Abbvie Inc has generated 13.94% jump in its net profits since last 3-months.
Abbvie Inc’s net profit margin fell -15.44% since last year same period to 10.8% in the Q3 2024. On a quarterly growth basis, Abbvie Inc has generated 13.96% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 2.92 |
EPS Estimate Current Year | 2.92 |
Abbvie Inc’s earning per share (EPS) estimates for the current quarter stand at 2.92 - a 13.62% jump from last quarter’s estimates.
Abbvie Inc’s earning per share (EPS) estimates for the current year stand at 2.92.
Earning Per Share (EPS) | 3 |
Dividend Per Share (DPS) | 1.55 |
Abbvie Inc’s earning per share (EPS) jumped 1.69% since last year same period to 3 in the Q3 2024. This indicates that the Abbvie Inc has generated 1.69% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Abbvie Inc declared 1.55 dividend per share during the earnings announcement for Q3 2024.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-11-04 | 2.92 | 3 | 2.74% |
2024-08-07 | 2.57 | 2.65 | 3.11% |
2024-05-03 | 2.23 | 2.31 | 3.59% |